A case of eczematous eruption occurring during treatment with risankizumab
Ital J Dermatol Venerol
.
2023 Feb;158(1):64-65.
doi: 10.23736/S2784-8671.22.07360-1.
Authors
Eleonora DE Luca
1
2
,
Giacomo Caldarola
3
2
,
Alessandro DI Stefani
1
2
,
Alessandra D'Amore
1
2
,
Stefania Sfregola
4
5
,
Clara DE Simone
1
2
Affiliations
1
Institute of Dermatology, Sacred Heart Catholic University, Rome, Italy.
2
Department of Dermatology, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
3
Institute of Dermatology, Sacred Heart Catholic University, Rome, Italy - giacomocaldarola@libero.it.
4
Section of Anatomic Pathology, Department of Life Sciences and Public Health, Sacred Heart Catholic University, Rome, Italy.
5
Unit of Anatomic Pathology, Department of Woman and Child Health and Public Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
PMID:
36939506
DOI:
10.23736/S2784-8671.22.07360-1
No abstract available
Publication types
Case Reports
MeSH terms
Antibodies, Monoclonal
Eczema* / chemically induced
Eczema* / drug therapy
Exanthema*
Humans
Substances
risankizumab
Antibodies, Monoclonal